A Houston startup that uses tech to speed up and lower the cost of home building will pitch at SXSW this year. Photo via 3spacemakers.com

Conroe-based construction tech company that specializes in creating technology to develop cost-efficient high-quality homes built in half the time is gearing up for new growth due to their recent selection as a finalist in SXSW Pitch 2020.

3Space Makers was at first selected as an alternate in the "Artificial Intelligence, Robotics & Voice" category for the 12th annual SXSW Pitch, formerly known as SXSW Accelerator, but was recently bumped to finalist.

"It's gratifying to learn that we have been selected," Ted Cox, CEO and co-founder of 3Space Makers, tells InnovationMap. "Our team has been working really hard for this moment. I think that not only do we have a good product, but the mission that we are on is what is resonating the most."

3Space Makers uses robotics, artificial intelligence, and 3D printing to spur innovation in the construction industry, allowing for faster manufacturing processes which, according to Cox, will enable homes to be built better, faster, and cheaper. The typical 3Space Makers home takes one month to build, drastically reducing the time frame of construction projects and thus reducing their cost.

"Everything in the construction industry right now is manual and human-driven," says Cox. "Until now that has been enough to get the job done. A typical home currently takes 3 to 6 months to build, 3Space Makers dramatically takes the inefficiencies out of the construction industry."

The company is developing new innovative technology marrying autonomous robotics and cloud-based control systems to produce detailed data to validate building standards. Their Fab & Fill process uses eco-friendly material known as BioSilicate to manufacture complete metal-framed walls and roofs using semi-automated processes.

The eco-friendly material can be made from natural materials native for particular regions such as corn husks and sugar cane, converting waste material into revenue for local farmers.

"We are building homes that are safe, durable, and affordable to those who are most in need using our processes," says Cox "We can cut the time of construction in about half along with the cost, that makes homes available for those who couldn't afford it otherwise, it's a bringing the promise of technology to the construction industry."

The idea for 3Space Makers was born out of the need to help vulnerable members of society, including low-income families and homeless veterans who cannot afford to buy a home with current high real estate prices.

The construction start-up aims to meet its '50/50/50' performance target to benefit veterans and low-income families.

"Any technology or process we develop," says Cox. "Must be 50 percent faster, 50 percent less expensive and 50 percent better than current methods on the market."

At their SXSW pitch, 3Space Makers will premiere as Integra Homes, a rebrand that represents a focus on increasing affordability for homes. The company is also currently working on raising a round of funding this year, along with gearing up to grow their facilities to finish their current projects, including building 5,000 homes in the U.S. and Jamaica.

"When we were originally founded, our focus was on serving homeless veterans, that remains to this day," says Cox. "But we also found that there is quite a need, not only in the U.S. for affordable homes. By being able to come in and build high-quality affordable homes with the help of our technological processes, it's going to make a big difference for many individuals."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.